Robert C. Pate, a director of Option Care Health, Inc., filed a Form 144 notice of proposed sale on November 10, 2026, covering 6,492 shares of common stock to be sold through Merrill Lynch.
Key Highlights
- Proposed seller: Robert C. Pate, identified in the filing as a Director of Option Care Health, Inc.
- Shares proposed for sale: 6,492 shares of common stock, with an aggregate market value of $207,750.
- Broker named: Merrill Lynch, 1033 Skokie Blvd., Suite 500, Northbrook, IL 60062.
- Approximate date of sale: November 10, 2026, on NASDAQ.
- Shares outstanding: 149,799,704 shares of common stock, according to the filing.
- Acquisition history: The shares were acquired via three stock award grants from the issuer on May 14, May 15, and May 17, 2026, totaling 6,492 shares, all classified as compensation.
- Prior sales: The filing reports nothing to disclose under securities sold during the past three months.
Robert C. Pate's Proposed Stock Award Share Sale at Option Care Health
According to the Form 144 filing submitted November 10, 2026, Robert C. Pate, a director of Option Care Health, Inc. (NASDAQ:OPCH), intends to sell 6,492 shares of the company's common stock. The filing lists an aggregate market value of $207,750 for the proposed sale and identifies Merrill Lynch in Northbrook, Illinois as the named broker.
The filing discloses that the 6,492 shares proposed for sale were acquired through three separate stock award transactions directly from the issuer, all described as compensation. Specifically, 1,678 shares were acquired on May 14, 2026; 1,775 shares on May 15, 2026; and 3,039 shares on May 17, 2026. The filing notes no securities of Option Care Health were sold by Pate during the three months preceding this notice.
The company's SEC file number is listed as 001-11993, and its principal address is 3000 Lakeside Drive, Suite 300 N, Bannockburn, Illinois 60015. The total shares of common stock outstanding are reported in the filing as 149,799,704. By signing the notice, the filer represented, as stated in the form, that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed."
What Was Disclosed
A Form 144 notice filed November 10, 2026, disclosed that Option Care Health director Robert C. Pate proposes to sell 6,492 shares of common stock, acquired through stock award grants in May 2026, with an aggregate market value of $207,750.



Please wait processing your request...